Global Oncology Based In-vitro CRO Market Growth (Status and Outlook) 2025-2031

September 2025 | 103 pages | ID: G2C2AA27C6CEEN
LP Information

Abstracts

According to this study, the global Oncology Based In-vitro CRO market size will reach US$ million by 2031.

Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible. This report focus on Oncology Based In-vitro CRO.

United States market for Oncology Based In-vitro CRO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Oncology Based In-vitro CRO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Oncology Based In-vitro CRO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Oncology Based In-vitro CRO players cover Crown Bioscience, Charles River Laboratory, ICON Plc., Eurofins Scientific, Taconic Biosciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Oncology Based In-vitro CRO Industry Forecast” looks at past sales and reviews total world Oncology Based In-vitro CRO sales in 2024, providing a comprehensive analysis by region and market sector of projected Oncology Based In-vitro CRO sales for 2025 through 2031. With Oncology Based In-vitro CRO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncology Based In-vitro CRO industry.

This Insight Report provides a comprehensive analysis of the global Oncology Based In-vitro CRO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oncology Based In-vitro CRO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncology Based In-vitro CRO market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncology Based In-vitro CRO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncology Based In-vitro CRO.

This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Based In-vitro CRO market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Blood Cancer
• Solid Tumors
• Other

Segmentation by Application:

• Pharmaceutical & Biopharmaceutical Industries
• Medical Device Companies
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Crown Bioscience
• Charles River Laboratory
• ICON Plc.
• Eurofins Scientific
• Taconic Biosciences
• Covance
• EVOTEC
• The Jackson Laboratory
• Wuxi AppTec.
• MI Bioresearch, Inc.
• Champion Oncology, Inc.
• Xentech

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Oncology Based In-vitro CRO Market Size (2020-2031)
  2.1.2 Oncology Based In-vitro CRO Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Oncology Based In-vitro CRO by Country/Region (2020, 2024 & 2031)
2.2 Oncology Based In-vitro CRO Segment by Type
  2.2.1 Blood Cancer
  2.2.2 Solid Tumors
  2.2.3 Other
2.3 Oncology Based In-vitro CRO Market Size by Type
  2.3.1 Oncology Based In-vitro CRO Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Oncology Based In-vitro CRO Market Size Market Share by Type (2020-2025)
2.4 Oncology Based In-vitro CRO Segment by Application
  2.4.1 Pharmaceutical & Biopharmaceutical Industries
  2.4.2 Medical Device Companies
  2.4.3 Others
2.5 Oncology Based In-vitro CRO Market Size by Application
  2.5.1 Oncology Based In-vitro CRO Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Oncology Based In-vitro CRO Market Size Market Share by Application (2020-2025)

3 ONCOLOGY BASED IN-VITRO CRO MARKET SIZE BY PLAYER

3.1 Oncology Based In-vitro CRO Market Size Market Share by Player
  3.1.1 Global Oncology Based In-vitro CRO Revenue by Player (2020-2025)
  3.1.2 Global Oncology Based In-vitro CRO Revenue Market Share by Player (2020-2025)
3.2 Global Oncology Based In-vitro CRO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ONCOLOGY BASED IN-VITRO CRO BY REGION

4.1 Oncology Based In-vitro CRO Market Size by Region (2020-2025)
4.2 Global Oncology Based In-vitro CRO Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oncology Based In-vitro CRO Market Size Growth (2020-2025)
4.4 APAC Oncology Based In-vitro CRO Market Size Growth (2020-2025)
4.5 Europe Oncology Based In-vitro CRO Market Size Growth (2020-2025)
4.6 Middle East & Africa Oncology Based In-vitro CRO Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Oncology Based In-vitro CRO Market Size by Country (2020-2025)
5.2 Americas Oncology Based In-vitro CRO Market Size by Type (2020-2025)
5.3 Americas Oncology Based In-vitro CRO Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Oncology Based In-vitro CRO Market Size by Region (2020-2025)
6.2 APAC Oncology Based In-vitro CRO Market Size by Type (2020-2025)
6.3 APAC Oncology Based In-vitro CRO Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Oncology Based In-vitro CRO Market Size by Country (2020-2025)
7.2 Europe Oncology Based In-vitro CRO Market Size by Type (2020-2025)
7.3 Europe Oncology Based In-vitro CRO Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Oncology Based In-vitro CRO by Region (2020-2025)
8.2 Middle East & Africa Oncology Based In-vitro CRO Market Size by Type (2020-2025)
8.3 Middle East & Africa Oncology Based In-vitro CRO Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ONCOLOGY BASED IN-VITRO CRO MARKET FORECAST

10.1 Global Oncology Based In-vitro CRO Forecast by Region (2026-2031)
  10.1.1 Global Oncology Based In-vitro CRO Forecast by Region (2026-2031)
  10.1.2 Americas Oncology Based In-vitro CRO Forecast
  10.1.3 APAC Oncology Based In-vitro CRO Forecast
  10.1.4 Europe Oncology Based In-vitro CRO Forecast
  10.1.5 Middle East & Africa Oncology Based In-vitro CRO Forecast
10.2 Americas Oncology Based In-vitro CRO Forecast by Country (2026-2031)
  10.2.1 United States Market Oncology Based In-vitro CRO Forecast
  10.2.2 Canada Market Oncology Based In-vitro CRO Forecast
  10.2.3 Mexico Market Oncology Based In-vitro CRO Forecast
  10.2.4 Brazil Market Oncology Based In-vitro CRO Forecast
10.3 APAC Oncology Based In-vitro CRO Forecast by Region (2026-2031)
  10.3.1 China Oncology Based In-vitro CRO Market Forecast
  10.3.2 Japan Market Oncology Based In-vitro CRO Forecast
  10.3.3 Korea Market Oncology Based In-vitro CRO Forecast
  10.3.4 Southeast Asia Market Oncology Based In-vitro CRO Forecast
  10.3.5 India Market Oncology Based In-vitro CRO Forecast
  10.3.6 Australia Market Oncology Based In-vitro CRO Forecast
10.4 Europe Oncology Based In-vitro CRO Forecast by Country (2026-2031)
  10.4.1 Germany Market Oncology Based In-vitro CRO Forecast
  10.4.2 France Market Oncology Based In-vitro CRO Forecast
  10.4.3 UK Market Oncology Based In-vitro CRO Forecast
  10.4.4 Italy Market Oncology Based In-vitro CRO Forecast
  10.4.5 Russia Market Oncology Based In-vitro CRO Forecast
10.5 Middle East & Africa Oncology Based In-vitro CRO Forecast by Region (2026-2031)
  10.5.1 Egypt Market Oncology Based In-vitro CRO Forecast
  10.5.2 South Africa Market Oncology Based In-vitro CRO Forecast
  10.5.3 Israel Market Oncology Based In-vitro CRO Forecast
  10.5.4 Turkey Market Oncology Based In-vitro CRO Forecast
10.6 Global Oncology Based In-vitro CRO Forecast by Type (2026-2031)
10.7 Global Oncology Based In-vitro CRO Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Oncology Based In-vitro CRO Forecast

11 KEY PLAYERS ANALYSIS

11.1 Crown Bioscience
  11.1.1 Crown Bioscience Company Information
  11.1.2 Crown Bioscience Oncology Based In-vitro CRO Product Offered
  11.1.3 Crown Bioscience Oncology Based In-vitro CRO Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Crown Bioscience Main Business Overview
  11.1.5 Crown Bioscience Latest Developments
11.2 Charles River Laboratory
  11.2.1 Charles River Laboratory Company Information
  11.2.2 Charles River Laboratory Oncology Based In-vitro CRO Product Offered
  11.2.3 Charles River Laboratory Oncology Based In-vitro CRO Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Charles River Laboratory Main Business Overview
  11.2.5 Charles River Laboratory Latest Developments
11.3 ICON Plc.
  11.3.1 ICON Plc. Company Information
  11.3.2 ICON Plc. Oncology Based In-vitro CRO Product Offered
  11.3.3 ICON Plc. Oncology Based In-vitro CRO Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 ICON Plc. Main Business Overview
  11.3.5 ICON Plc. Latest Developments
11.4 Eurofins Scientific
  11.4.1 Eurofins Scientific Company Information
  11.4.2 Eurofins Scientific Oncology Based In-vitro CRO Product Offered
  11.4.3 Eurofins Scientific Oncology Based In-vitro CRO Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Eurofins Scientific Main Business Overview
  11.4.5 Eurofins Scientific Latest Developments
11.5 Taconic Biosciences
  11.5.1 Taconic Biosciences Company Information
  11.5.2 Taconic Biosciences Oncology Based In-vitro CRO Product Offered
  11.5.3 Taconic Biosciences Oncology Based In-vitro CRO Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Taconic Biosciences Main Business Overview
  11.5.5 Taconic Biosciences Latest Developments
11.6 Covance
  11.6.1 Covance Company Information
  11.6.2 Covance Oncology Based In-vitro CRO Product Offered
  11.6.3 Covance Oncology Based In-vitro CRO Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Covance Main Business Overview
  11.6.5 Covance Latest Developments
11.7 EVOTEC
  11.7.1 EVOTEC Company Information
  11.7.2 EVOTEC Oncology Based In-vitro CRO Product Offered
  11.7.3 EVOTEC Oncology Based In-vitro CRO Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 EVOTEC Main Business Overview
  11.7.5 EVOTEC Latest Developments
11.8 The Jackson Laboratory
  11.8.1 The Jackson Laboratory Company Information
  11.8.2 The Jackson Laboratory Oncology Based In-vitro CRO Product Offered
  11.8.3 The Jackson Laboratory Oncology Based In-vitro CRO Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 The Jackson Laboratory Main Business Overview
  11.8.5 The Jackson Laboratory Latest Developments
11.9 Wuxi AppTec.
  11.9.1 Wuxi AppTec. Company Information
  11.9.2 Wuxi AppTec. Oncology Based In-vitro CRO Product Offered
  11.9.3 Wuxi AppTec. Oncology Based In-vitro CRO Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Wuxi AppTec. Main Business Overview
  11.9.5 Wuxi AppTec. Latest Developments
11.10 MI Bioresearch, Inc.
  11.10.1 MI Bioresearch, Inc. Company Information
  11.10.2 MI Bioresearch, Inc. Oncology Based In-vitro CRO Product Offered
  11.10.3 MI Bioresearch, Inc. Oncology Based In-vitro CRO Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 MI Bioresearch, Inc. Main Business Overview
  11.10.5 MI Bioresearch, Inc. Latest Developments
11.11 Champion Oncology, Inc.
  11.11.1 Champion Oncology, Inc. Company Information
  11.11.2 Champion Oncology, Inc. Oncology Based In-vitro CRO Product Offered
  11.11.3 Champion Oncology, Inc. Oncology Based In-vitro CRO Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Champion Oncology, Inc. Main Business Overview
  11.11.5 Champion Oncology, Inc. Latest Developments
11.12 Xentech
  11.12.1 Xentech Company Information
  11.12.2 Xentech Oncology Based In-vitro CRO Product Offered
  11.12.3 Xentech Oncology Based In-vitro CRO Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Xentech Main Business Overview
  11.12.5 Xentech Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Oncology Based In-vitro CRO Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Oncology Based In-vitro CRO Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Blood Cancer
Table 4. Major Players of Solid Tumors
Table 5. Major Players of Other
Table 6. Oncology Based In-vitro CRO Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Oncology Based In-vitro CRO Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Oncology Based In-vitro CRO Market Size Market Share by Type (2020-2025)
Table 9. Oncology Based In-vitro CRO Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Oncology Based In-vitro CRO Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Oncology Based In-vitro CRO Market Size Market Share by Application (2020-2025)
Table 12. Global Oncology Based In-vitro CRO Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Oncology Based In-vitro CRO Revenue Market Share by Player (2020-2025)
Table 14. Oncology Based In-vitro CRO Key Players Head office and Products Offered
Table 15. Oncology Based In-vitro CRO Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Oncology Based In-vitro CRO Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Oncology Based In-vitro CRO Market Size Market Share by Region (2020-2025)
Table 20. Global Oncology Based In-vitro CRO Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Oncology Based In-vitro CRO Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Oncology Based In-vitro CRO Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Oncology Based In-vitro CRO Market Size Market Share by Country (2020-2025)
Table 24. Americas Oncology Based In-vitro CRO Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Oncology Based In-vitro CRO Market Size Market Share by Type (2020-2025)
Table 26. Americas Oncology Based In-vitro CRO Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Oncology Based In-vitro CRO Market Size Market Share by Application (2020-2025)
Table 28. APAC Oncology Based In-vitro CRO Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Oncology Based In-vitro CRO Market Size Market Share by Region (2020-2025)
Table 30. APAC Oncology Based In-vitro CRO Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Oncology Based In-vitro CRO Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Oncology Based In-vitro CRO Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Oncology Based In-vitro CRO Market Size Market Share by Country (2020-2025)
Table 34. Europe Oncology Based In-vitro CRO Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Oncology Based In-vitro CRO Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Oncology Based In-vitro CRO Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Oncology Based In-vitro CRO Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Oncology Based In-vitro CRO Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Oncology Based In-vitro CRO
Table 40. Key Market Challenges & Risks of Oncology Based In-vitro CRO
Table 41. Key Industry Trends of Oncology Based In-vitro CRO
Table 42. Global Oncology Based In-vitro CRO Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Oncology Based In-vitro CRO Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Oncology Based In-vitro CRO Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Oncology Based In-vitro CRO Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Crown Bioscience Details, Company Type, Oncology Based In-vitro CRO Area Served and Its Competitors
Table 47. Crown Bioscience Oncology Based In-vitro CRO Product Offered
Table 48. Crown Bioscience Oncology Based In-vitro CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Crown Bioscience Main Business
Table 50. Crown Bioscience Latest Developments
Table 51. Charles River Laboratory Details, Company Type, Oncology Based In-vitro CRO Area Served and Its Competitors
Table 52. Charles River Laboratory Oncology Based In-vitro CRO Product Offered
Table 53. Charles River Laboratory Oncology Based In-vitro CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Charles River Laboratory Main Business
Table 55. Charles River Laboratory Latest Developments
Table 56. ICON Plc. Details, Company Type, Oncology Based In-vitro CRO Area Served and Its Competitors
Table 57. ICON Plc. Oncology Based In-vitro CRO Product Offered
Table 58. ICON Plc. Oncology Based In-vitro CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. ICON Plc. Main Business
Table 60. ICON Plc. Latest Developments
Table 61. Eurofins Scientific Details, Company Type, Oncology Based In-vitro CRO Area Served and Its Competitors
Table 62. Eurofins Scientific Oncology Based In-vitro CRO Product Offered
Table 63. Eurofins Scientific Oncology Based In-vitro CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Eurofins Scientific Main Business
Table 65. Eurofins Scientific Latest Developments
Table 66. Taconic Biosciences Details, Company Type, Oncology Based In-vitro CRO Area Served and Its Competitors
Table 67. Taconic Biosciences Oncology Based In-vitro CRO Product Offered
Table 68. Taconic Biosciences Oncology Based In-vitro CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Taconic Biosciences Main Business
Table 70. Taconic Biosciences Latest Developments
Table 71. Covance Details, Company Type, Oncology Based In-vitro CRO Area Served and Its Competitors
Table 72. Covance Oncology Based In-vitro CRO Product Offered
Table 73. Covance Oncology Based In-vitro CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Covance Main Business
Table 75. Covance Latest Developments
Table 76. EVOTEC Details, Company Type, Oncology Based In-vitro CRO Area Served and Its Competitors
Table 77. EVOTEC Oncology Based In-vitro CRO Product Offered
Table 78. EVOTEC Oncology Based In-vitro CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. EVOTEC Main Business
Table 80. EVOTEC Latest Developments
Table 81. The Jackson Laboratory Details, Company Type, Oncology Based In-vitro CRO Area Served and Its Competitors
Table 82. The Jackson Laboratory Oncology Based In-vitro CRO Product Offered
Table 83. The Jackson Laboratory Oncology Based In-vitro CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. The Jackson Laboratory Main Business
Table 85. The Jackson Laboratory Latest Developments
Table 86. Wuxi AppTec. Details, Company Type, Oncology Based In-vitro CRO Area Served and Its Competitors
Table 87. Wuxi AppTec. Oncology Based In-vitro CRO Product Offered
Table 88. Wuxi AppTec. Oncology Based In-vitro CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Wuxi AppTec. Main Business
Table 90. Wuxi AppTec. Latest Developments
Table 91. MI Bioresearch, Inc. Details, Company Type, Oncology Based In-vitro CRO Area Served and Its Competitors
Table 92. MI Bioresearch, Inc. Oncology Based In-vitro CRO Product Offered
Table 93. MI Bioresearch, Inc. Oncology Based In-vitro CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. MI Bioresearch, Inc. Main Business
Table 95. MI Bioresearch, Inc. Latest Developments
Table 96. Champion Oncology, Inc. Details, Company Type, Oncology Based In-vitro CRO Area Served and Its Competitors
Table 97. Champion Oncology, Inc. Oncology Based In-vitro CRO Product Offered
Table 98. Champion Oncology, Inc. Oncology Based In-vitro CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Champion Oncology, Inc. Main Business
Table 100. Champion Oncology, Inc. Latest Developments
Table 101. Xentech Details, Company Type, Oncology Based In-vitro CRO Area Served and Its Competitors
Table 102. Xentech Oncology Based In-vitro CRO Product Offered
Table 103. Xentech Oncology Based In-vitro CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Xentech Main Business
Table 105. Xentech Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Oncology Based In-vitro CRO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncology Based In-vitro CRO Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Oncology Based In-vitro CRO Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Oncology Based In-vitro CRO Sales Market Share by Country/Region (2024)
Figure 8. Oncology Based In-vitro CRO Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Oncology Based In-vitro CRO Market Size Market Share by Type in 2024
Figure 10. Oncology Based In-vitro CRO in Pharmaceutical & Biopharmaceutical Industries
Figure 11. Global Oncology Based In-vitro CRO Market: Pharmaceutical & Biopharmaceutical Industries (2020-2025) & ($ millions)
Figure 12. Oncology Based In-vitro CRO in Medical Device Companies
Figure 13. Global Oncology Based In-vitro CRO Market: Medical Device Companies (2020-2025) & ($ millions)
Figure 14. Oncology Based In-vitro CRO in Others
Figure 15. Global Oncology Based In-vitro CRO Market: Others (2020-2025) & ($ millions)
Figure 16. Global Oncology Based In-vitro CRO Market Size Market Share by Application in 2024
Figure 17. Global Oncology Based In-vitro CRO Revenue Market Share by Player in 2024
Figure 18. Global Oncology Based In-vitro CRO Market Size Market Share by Region (2020-2025)
Figure 19. Americas Oncology Based In-vitro CRO Market Size 2020-2025 ($ millions)
Figure 20. APAC Oncology Based In-vitro CRO Market Size 2020-2025 ($ millions)
Figure 21. Europe Oncology Based In-vitro CRO Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Oncology Based In-vitro CRO Market Size 2020-2025 ($ millions)
Figure 23. Americas Oncology Based In-vitro CRO Value Market Share by Country in 2024
Figure 24. United States Oncology Based In-vitro CRO Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Oncology Based In-vitro CRO Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Oncology Based In-vitro CRO Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Oncology Based In-vitro CRO Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Oncology Based In-vitro CRO Market Size Market Share by Region in 2024
Figure 29. APAC Oncology Based In-vitro CRO Market Size Market Share by Type (2020-2025)
Figure 30. APAC Oncology Based In-vitro CRO Market Size Market Share by Application (2020-2025)
Figure 31. China Oncology Based In-vitro CRO Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Oncology Based In-vitro CRO Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Oncology Based In-vitro CRO Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Oncology Based In-vitro CRO Market Size Growth 2020-2025 ($ millions)
Figure 35. India Oncology Based In-vitro CRO Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Oncology Based In-vitro CRO Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Oncology Based In-vitro CRO Market Size Market Share by Country in 2024
Figure 38. Europe Oncology Based In-vitro CRO Market Size Market Share by Type (2020-2025)
Figure 39. Europe Oncology Based In-vitro CRO Market Size Market Share by Application (2020-2025)
Figure 40. Germany Oncology Based In-vitro CRO Market Size Growth 2020-2025 ($ millions)
Figure 41. France Oncology Based In-vitro CRO Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Oncology Based In-vitro CRO Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Oncology Based In-vitro CRO Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Oncology Based In-vitro CRO Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Oncology Based In-vitro CRO Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Oncology Based In-vitro CRO Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Oncology Based In-vitro CRO Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Oncology Based In-vitro CRO Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Oncology Based In-vitro CRO Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Oncology Based In-vitro CRO Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Oncology Based In-vitro CRO Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Oncology Based In-vitro CRO Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Oncology Based In-vitro CRO Market Size 2026-2031 ($ millions)
Figure 54. APAC Oncology Based In-vitro CRO Market Size 2026-2031 ($ millions)
Figure 55. Europe Oncology Based In-vitro CRO Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Oncology Based In-vitro CRO Market Size 2026-2031 ($ millions)
Figure 57. United States Oncology Based In-vitro CRO Market Size 2026-2031 ($ millions)
Figure 58. Canada Oncology Based In-vitro CRO Market Size 2026-2031 ($ millions)
Figure 59. Mexico Oncology Based In-vitro CRO Market Size 2026-2031 ($ millions)
Figure 60. Brazil Oncology Based In-vitro CRO Market Size 2026-2031 ($ millions)
Figure 61. China Oncology Based In-vitro CRO Market Size 2026-2031 ($ millions)
Figure 62. Japan Oncology Based In-vitro CRO Market Size 2026-2031 ($ millions)
Figure 63. Korea Oncology Based In-vitro CRO Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Oncology Based In-vitro CRO Market Size 2026-2031 ($ millions)
Figure 65. India Oncology Based In-vitro CRO Market Size 2026-2031 ($ millions)
Figure 66. Australia Oncology Based In-vitro CRO Market Size 2026-2031 ($ millions)
Figure 67. Germany Oncology Based In-vitro CRO Market Size 2026-2031 ($ millions)
Figure 68. France Oncology Based In-vitro CRO Market Size 2026-2031 ($ millions)
Figure 69. UK Oncology Based In-vitro CRO Market Size 2026-2031 ($ millions)
Figure 70. Italy Oncology Based In-vitro CRO Market Size 2026-2031 ($ millions)
Figure 71. Russia Oncology Based In-vitro CRO Market Size 2026-2031 ($ millions)
Figure 72. Egypt Oncology Based In-vitro CRO Market Size 2026-2031 ($ millions)
Figure 73. South Africa Oncology Based In-vitro CRO Market Size 2026-2031 ($ millions)
Figure 74. Israel Oncology Based In-vitro CRO Market Size 2026-2031 ($ millions)
Figure 75. Turkey Oncology Based In-vitro CRO Market Size 2026-2031 ($ millions)
Figure 76. Global Oncology Based In-vitro CRO Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Oncology Based In-vitro CRO Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Oncology Based In-vitro CRO Market Size 2026-2031 ($ millions)